Business

December 30, 2013

BioCryst receives another $2.5 million to develop Marburg virus drug

BioCryst Pharmaceuticals has received an additional $2.5 million in federal funding to further develop a treatment for Marburg virus disease.

Related content

Comments

Editor's Choice Videos